Categories: BrainNews

CervoMed to Participate in The Canaccord Genuity 44th Annual Growth Conference

BOSTON, July 30, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company’s Management will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference, to be held in Boston, MA, and participate in one-on-one investor meetings.

Presentation Details
Format: Fireside Chat
Date: Tuesday, August 13, 2024
Time: 12:30 PM ET
Webcast Link: https://wsw.com/webcast/canaccord98/crvo/2485318

The webcast of the fireside chat will be accessible in the Investors section of the CervoMed website https://www.cervomed.com/.

About CervoMed
CervoMed Inc. (the “Company”) is a clinical-stage company focused on developing treatments for age-related neurologic disorders. The Company is currently developing neflamapimod, an investigational, orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that causes disease in DLB and certain other major neurological disorders. Neflamapimod is currently being evaluated in a Phase 2b study in patients with DLB.

Investor Contact:
PJ Kelleher
LifeSci Advisors
Investors@cervomed.com
617-430-7579

Staff

Recent Posts

From AI to DNN: Starkey Shares a Deep Dive into Hearing Technology

Industry Leaders Dave Fabry, Ph.D. and Douglas L. Beck, Au.D. share insights to help providers…

35 mins ago

Innovative Anti-Nausea Smartwatch EmeTerm® Smart Set to Launch on Indiegogo

VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ -- EmeTerm® Smart uses patented hybrid technology to seamlessly…

35 mins ago

Employees First Announces Benefits-Captive-as-a-Service™ Model for Transparency in Voluntary Benefits

Innovative solution from a women-owned business seamlessly integrates the advantages of self-funding into fully-insured supplemental…

35 mins ago

Claigan Webinar – Canadian PFAS Reporting New – Section 71 Reporting of PFAS in Canada

OTTAWA, ON, Aug. 8, 2024 /PRNewswire/ - On August 14, Claigan Environmental Inc. (www.claigan.com) will…

35 mins ago

Label-Free Detection Market worth $747 million by 2029 driven by Technological Advancements | MarketsandMarkets™

CHICAGO, Aug. 8, 2024 /PRNewswire/ -- The global Label-Free Detection Market is expected to grow from…

35 mins ago

Modular Construction Launches at 58 Grattan in Bushwick, Brooklyn for IoT-Driven Mixed-Use Office Building

One of the first structures of its kind in the neighborhood, the building will be…

35 mins ago